FORTIS.NS Profit & Loss
Fortis Healthcare Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 8 years on file
(FY2018-19 to FY2025-26)
· fetched 2026-08-24 01:36
| Line item | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹4,469.36 Cr. | ₹4,632.32 Cr. | ₹4,030.12 Cr. | ₹5,717.61 Cr. | ₹6,297.63 Cr. | ₹6,892.92 Cr. | ₹7,782.75 Cr. | ₹9,127.84 Cr. | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | ₹4,469.36 Cr. | ₹4,632.32 Cr. | ₹4,030.12 Cr. | ₹5,717.61 Cr. | ₹6,297.63 Cr. | ₹6,892.92 Cr. | ₹7,782.75 Cr. | ₹9,127.84 Cr. | SegmentRevenueFromOperations |
| Other Income | ₹92.40 Cr. | ₹52.64 Cr. | ₹46.56 Cr. | ₹27.34 Cr. | ₹61.72 Cr. | ₹38.25 Cr. | ₹66.94 Cr. | ₹50.66 Cr. | OtherIncome |
| Total Income | ₹4,561.76 Cr. | ₹4,684.96 Cr. | ₹4,076.68 Cr. | ₹5,744.95 Cr. | ₹6,359.35 Cr. | ₹6,931.17 Cr. | ₹7,849.69 Cr. | ₹9,178.50 Cr. | Income |
| Cost of Materials Consumed | ₹928.24 Cr. | ₹963.85 Cr. | ₹975.90 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹1,403.37 Cr. | ₹1,454.65 Cr. | ₹1,603.25 Cr. | ₹1,838.07 Cr. | ₹2,108.65 Cr. | PurchasesOfStockInTrade |
| Changes in Inventories | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹-46.14 Cr. | ₹0.06 Cr. | ₹15.43 Cr. | ₹-7.88 Cr. | ₹-19.98 Cr. | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹913.59 Cr. | ₹916.03 Cr. | ₹849.01 Cr. | ₹972.94 Cr. | ₹1,046.88 Cr. | ₹1,119.53 Cr. | ₹1,167.24 Cr. | ₹1,296.63 Cr. | EmployeeBenefitExpense |
| Finance Costs | ₹336.83 Cr. | ₹205.06 Cr. | ₹165.88 Cr. | ₹146.85 Cr. | ₹129.09 Cr. | ₹130.95 Cr. | ₹184.41 Cr. | ₹314.47 Cr. | FinanceCosts |
| Depreciation and Amortisation | ₹232.92 Cr. | ₹291.73 Cr. | ₹290.60 Cr. | ₹300.84 Cr. | ₹315.74 Cr. | ₹342.50 Cr. | ₹385.61 Cr. | ₹449.43 Cr. | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹2,402.31 Cr. | ₹2,142.92 Cr. | ₹1,800.77 Cr. | ₹2,318.48 Cr. | ₹2,694.70 Cr. | ₹2,887.07 Cr. | ₹3,197.38 Cr. | ₹3,657.56 Cr. | OtherExpenses |
| Total Expenses | ₹4,813.89 Cr. | ₹4,519.59 Cr. | ₹4,082.16 Cr. | ₹5,096.34 Cr. | ₹5,641.12 Cr. | ₹6,098.73 Cr. | ₹6,764.83 Cr. | ₹7,806.76 Cr. | Expenses |
| Profit Before Exceptional Items and Tax | ₹-252.13 Cr. | ₹165.37 Cr. | ₹-5.48 Cr. | ₹648.61 Cr. | ₹718.23 Cr. | ₹832.44 Cr. | ₹1,084.86 Cr. | ₹1,371.74 Cr. | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹-222.38 Cr. | ₹61.83 Cr. | ₹1.21 Cr. | ₹315.03 Cr. | ₹73.61 Cr. | ₹16.02 Cr. | ₹-89.34 Cr. | ₹-22.24 Cr. | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹-474.51 Cr. | ₹227.20 Cr. | ₹-4.27 Cr. | ₹963.64 Cr. | ₹791.84 Cr. | ₹848.46 Cr. | ₹995.52 Cr. | ₹1,349.50 Cr. | ProfitBeforeTax |
| Tax Expense | ₹113.61 Cr. | ₹147.87 Cr. | ₹99.46 Cr. | ₹197.84 Cr. | ₹180.70 Cr. | ₹212.75 Cr. | ₹197.66 Cr. | ₹301.66 Cr. | TaxExpense |
| Net Profit (incl. minority interest) | ₹-223.71 Cr. | ₹91.49 Cr. | ₹-56.17 Cr. | ₹789.95 Cr. | ₹632.98 Cr. | ₹645.22 Cr. | ₹809.38 Cr. | ₹1,064.19 Cr. | ProfitLossForPeriod |
| Net Profit (to shareholders) | N/A | ₹135.60 Cr. | ₹-109.76 Cr. | ₹555.12 Cr. | ₹588.73 Cr. | ₹598.88 Cr. | ₹774.21 Cr. | ₹1,041.78 Cr. | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹-3.70 | ₹0.77 | ₹-1.45 | ₹7.35 | ₹7.80 | ₹7.93 | ₹10.26 | ₹13.80 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹-3.70 | ₹0.77 | ₹-1.45 | ₹7.35 | ₹7.80 | ₹7.93 | ₹10.26 | ₹13.80 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from FORTIS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).